[ad_1] Nearly 12% of Americans have used GLP-1 drugs for weight loss, including about one-fifth of women aged 50 to 64, according to a new RAND report. Surveying a nationally representative sample of 8,793 Americans, researchers found that 11.8% have used GLP-1 agonists and 14% say they are interested in using the drugs. Meanwhile, 74%...
[ad_1] The National Institute for Health and Care Excellence (NICE) has released updated guidance recommending that healthcare providers offer structured, ongoing support to patients after they complete obesity treatment or stop taking weight-loss medications. This includes regular follow-up care, tailored action plans, and social support to help patients maintain their weight loss and avoid regaining...
[ad_1] Veterinary students from Washington State University talk to a patient about their cat’s health at the Seattle One Health Clinic. A new study led by the UW found that integrating veterinary and human health care increased access to preventative care for both people and their pets. Credit: Prenz Sa-Ngoun Every year, nearly 2 million...
[ad_1] Researchers at Kyoto University have discovered that an immune molecule found only in primates, called IGFL2, plays a key role in regulating inflammation in rheumatoid arthritis (RA). IGFL2 is produced by a subset of immune cells in the joints of patients with RA and acts like fuel on a fire: it activates more immune...
[ad_1] New research from UC San Diego has revealed fascinating insights into how timing our meals might significantly affect our metabolic health by aligning with our body’s natural microbial rhythms. Just as our bodies follow circadian rhythms, our gut microbes have their own daily patterns, with certain beneficial activities increasing during our active periods to...
[ad_1] High-resolution 3D image showing how the 5-HT1A receptor connects with internal signaling proteins (G proteins). The highlighted areas reveal key contact points between the receptor and two different types of G proteins, captured using advanced cryo-electron microscopy. Credit: From A.L Warren et al., Structural determinants of G protein subtype selectivity at the serotonin receptor...
[ad_1] The University of Colorado Anschutz Medical Campus will lead a groundbreaking national clinical trial-supported by a $29 million grant from Octapharma-to evaluate whether early replacement of fibrinogen, a critical blood clotting mechanism in the body, can improve outcomes for trauma patients experiencing life-threatening bleeding. This investigator-initiated study is one of the largest clinical trial...
[ad_1] A sharp rise in Shiga toxin-producing Escherichia coli (STEC) infections was recorded in England in 2024, new figures from the UK Health Security Agency (UKHSA) show. There were 2544 culture-confirmed cases, up 26% from the 2018 cases recorded in 2023. Of these, 564 were STEC serotype O157 and 1980 were non-O157 strains. The UKHSA...
[ad_1] For women diagnosed with breast cancer at age 40 years or younger, the risk for isolated locoregional recurrence (LRR) is relatively low, according to a study published online July 23 in JAMA Surgery. Laura S. Dominici, M.D., from Brigham and Women’s Hospital in Boston, and colleagues examined the long-term incidence of isolated LRR by...
[ad_1] A new review was published in Volume 16 of Oncotarget on June 25, 2025, titled “Challenges and resistance mechanisms to EGFR targeted therapies in head and neck cancers and breast cancer: Insights into RTK dependent and independent mechanisms.” Researchers from the University of Cincinnati and Cincinnati Veterans Affairs Medical Center reviewed current research on why Epidermal Growth Factor Receptor (EGFR)-targeted therapies...
